Women's Hospital of Jiangnan University, No. 48, Huaishu Lane, Wuxi, Jiangsu, China.
Baoding No. 1 Hospital of TCM, Baoding, Hebei, China.
Ann Clin Microbiol Antimicrob. 2023 Jan 13;22(1):5. doi: 10.1186/s12941-023-00553-7.
Maternal rectovaginal colonization with group B Streptococcus (GBS) or Streptococcus agalactiae is the most common pathway for this disease during the perinatal period. This meta-analysis aimed to summarize existing data regarding maternal colonization, serotype profiles, and antibiotic resistance in China.
Systematic literature reviews were conducted after searching 6 databases. Meta-analysis was applied to analyze colonization rate, serotype, and antimicrobial susceptibility of GBS clinical isolates in different regions of China. Summary estimates are presented using tables, funnel plots, forest plots, histograms, violin plots, and line plots.
The dataset regarding colonization included 52 articles and 195 303 pregnant women. Our estimate for maternal GBS colonization in China was 8.1% (95% confidence interval [CI] 7.2%-8.9%). Serotypes Ia, Ib, III, and V account for 95.9% of identified isolates. Serotype III, which is frequently associated with the hypervirulent clonal complex, accounts for 46.4%. Among the maternal GBS isolates using multilocus sequence typing (MLST), ST19 (25.7%, 289/1126) and ST10 (25.1%, 283/1126) were most common, followed by ST12 (12.4%, 140/1126), ST17 (4.8%, 54/1126), and ST651 (3.7%, 42/1126). GBS was highly resistant to tetracycline (75.1% [95% CI 74.0-76.3%]) and erythromycin (65.4% [95% CI 64.5-66.3%]) and generally susceptible to penicillin, ampicillin, vancomycin, ceftriaxone, and linezolid. Resistance rates of GBS to clindamycin and levofloxacin varied greatly (1.0-99.2% and 10.3-72.9%, respectively). A summary analysis of the bacterial drug resistance reports released by the China Antimicrobial Resistance Surveillance System (CARSS) in the past 5 years showed that the drug resistance rate of GBS to erythromycin, clindamycin, and levofloxacin decreased slowly from 2018 to 2020. However, the resistance rates of GBS to all 3 antibiotics increased slightly in 2021.
The overall colonization rate in China was much lower than the global colonization rate (17.4%). Consistent with many original and review reports in other parts of the world, GBS was highly resistant to tetracycline. However, the resistance of GBS isolates in China to erythromycin and clindamycin was greater than in other countries. This paper provides important epidemiological information, to assist with prevention and treatment of GBS colonization in these women.
母婴直肠阴道定植 B 群链球菌(GBS)或无乳链球菌是围产期该病最常见的途径。本荟萃分析旨在总结中国关于母婴定植、血清型谱和抗生素耐药性的现有数据。
在检索了 6 个数据库后进行系统文献综述。采用荟萃分析分析了中国不同地区 GBS 临床分离株的定植率、血清型和抗菌药物敏感性。使用表格、漏斗图、森林图、直方图、小提琴图和线图汇总估计值。
关于定植的数据集中包括 52 篇文章和 195303 名孕妇。我们在中国的母婴 GBS 定植率估计为 8.1%(95%置信区间[CI]7.2%-8.9%)。血清型 Ia、Ib、III 和 V 占鉴定分离株的 95.9%。与高毒力克隆群密切相关的血清型 III 占 46.4%。在使用多位点序列分型(MLST)的母婴 GBS 分离株中,ST19(25.7%,289/1126)和 ST10(25.1%,283/1126)最为常见,其次是 ST12(12.4%,140/1126)、ST17(4.8%,54/1126)和 ST651(3.7%,42/1126)。GBS 对四环素(75.1%[95%CI74.0-76.3%])和红霉素(65.4%[95%CI64.5-66.3%])高度耐药,通常对青霉素、氨苄西林、万古霉素、头孢曲松和利奈唑胺敏感。GBS 对克林霉素和左氧氟沙星的耐药率差异很大(分别为 1.0-99.2%和 10.3-72.9%)。对过去 5 年中国抗菌药物耐药性监测系统(CARSS)发布的细菌药物耐药性报告进行汇总分析显示,GBS 对红霉素、克林霉素和左氧氟沙星的耐药率从 2018 年到 2020 年缓慢下降。然而,2021 年 GBS 对所有 3 种抗生素的耐药率均略有上升。
中国的总体定植率远低于全球定植率(17.4%)。与世界其他地区的许多原始和综述报告一致,GBS 对四环素高度耐药。然而,中国 GBS 分离株对红霉素和克林霉素的耐药性大于其他国家。本文提供了重要的流行病学信息,以协助这些女性的 GBS 定植的预防和治疗。